Trial intelligence / Profile preview

Effect of Various Medications on Emotional and Sensory Information Processing in Healthy Volunteers

2012-002476-14Phase 4Completed

Sponsor
Jesper Ekelund
Start
Feb 2013
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of citalopram, escitalopram, reboxetine, mirtazapine, duloxetine and 6 more (11 arms), sponsored by Jesper Ekelund. Primary endpoints: Change in emotional processing, Change in attention and 2 more. Started Feb 2013; status: completed.

02

Drugs

citalopramescitalopramreboxetinemirtazapineduloxetine

Beyond the preview

Go deeper on 2012-002476-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002476-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call